As of April 19, 2025, Coya Therapeutics (COYA) has a market cap of $87.974 million USD. According to our data, Coya Therapeutics is ranked No.7685 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $87.97 M |
-8.11%
|
Dec 31, 2024 | $95.73 M |
-22.67%
|
Dec 29, 2023 | $0.12 B |
56.40%
|
Dec 30, 2022 | $79.16 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Aadi Bioscience
AADI
|
$94.89 M |
4.629 M
|
![]() USA
|
![]() Sana Biotechnology
SANA
|
$0.37 B |
0.000 M
|
![]() USA
|
![]() Astellas Pharma
4503.T
|
$17.03 B |
0.001 M
|
![]() Japan
|
![]() Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
![]() USA
|
![]() Moderna
MRNA
|
$9.56 B |
-0.000 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
-0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.75 B |
-0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.70 B |
0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.26 B |
0.000 M
|
![]() Switzerland
|
![]() Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
![]() USA
|
![]() Novartis
NVS
|
$219.89 B |
0.932 B
|
![]() Switzerland
|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
Market Cap | = | COYA Stock Price | * | COYA Shares Outstanding |
= | $5.26 | * | 16.73 M | |
= | $87.97 M |